Daré Bioscience Investor Relations Material
Latest events
Q4 2023
Daré Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Daré Bioscience Inc
Access all reports
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing and marketing products for women's health. The firm focuses on women's reproductive health management which includes contraception and treatment of endometriosis and infertility. Daré Bioscience is developing VASCAZEN as a nonhormonal oral contraceptive that is intended to have no estrogen or progestin side effects such as weight gain and fluid retention as well as its potential effect by regulatory authorities to make it available more quickly than fully approved new drugs.
Key slides for Daré Bioscience Inc
Corporate Presentation
Daré Bioscience Inc
Corporate Presentation
Daré Bioscience Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States